DK72784A - Imidazo-heterocycliske forbindelser - Google Patents

Imidazo-heterocycliske forbindelser Download PDF

Info

Publication number
DK72784A
DK72784A DK72784A DK72784A DK72784A DK 72784 A DK72784 A DK 72784A DK 72784 A DK72784 A DK 72784A DK 72784 A DK72784 A DK 72784A DK 72784 A DK72784 A DK 72784A
Authority
DK
Denmark
Prior art keywords
lower alkyl
substituted
hydrogen
optionally substituted
pyridyl
Prior art date
Application number
DK72784A
Other languages
English (en)
Other versions
DK72784D0 (da
Inventor
Takao Takaya
Hisashi Takasugi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK72784D0 publication Critical patent/DK72784D0/da
Publication of DK72784A publication Critical patent/DK72784A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK72784A 1983-02-25 1984-02-16 Imidazo-heterocycliske forbindelser DK72784A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838305245A GB8305245D0 (en) 1983-02-25 1983-02-25 Imidazo-heterocyclic compounds

Publications (2)

Publication Number Publication Date
DK72784D0 DK72784D0 (da) 1984-02-16
DK72784A true DK72784A (da) 1984-08-26

Family

ID=10538591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK72784A DK72784A (da) 1983-02-25 1984-02-16 Imidazo-heterocycliske forbindelser

Country Status (14)

Country Link
US (1) US4621084A (da)
EP (1) EP0120589B1 (da)
JP (1) JPS59186983A (da)
KR (1) KR840007879A (da)
AT (1) ATE34984T1 (da)
AU (1) AU2482284A (da)
DE (1) DE3471936D1 (da)
DK (1) DK72784A (da)
ES (1) ES530011A0 (da)
FI (1) FI840653A (da)
GB (1) GB8305245D0 (da)
GR (1) GR79810B (da)
NO (1) NO840712L (da)
ZA (1) ZA841156B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
GB8432073D0 (en) * 1984-12-19 1985-01-30 Roussel Lab Ltd Chemical compounds
DE3446812A1 (de) * 1984-12-21 1986-06-26 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
WO1986007059A2 (en) * 1985-05-25 1986-12-04 Yoshitomi Pharmaceutical Industries, Ltd. Oxodiazine compounds
CA1256109A (en) * 1986-09-10 1989-06-20 Franz Rovenszky Process for the preparation of derivatives of 4, 5-dihydrooxazoles
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
EP0266890A1 (en) * 1986-10-07 1988-05-11 Yamanouchi Pharmaceutical Co. Ltd. Imidazopyridine derivatives, their production, and pharmaceutical compositions containing them
US4731446A (en) * 1987-05-01 1988-03-15 The Dow Chemical Company Imidazo[1,2-a]pyrimidine sulfonic acids and acid halides
GB8820231D0 (en) * 1988-08-25 1988-09-28 Fujisawa Pharmaceutical Co New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same
EP0375819A1 (en) * 1988-12-20 1990-07-04 Merrell Dow Pharmaceuticals Inc. Novel derivatives of 1,7'-[imidazo-[1,2-a]pyridine]5'-(6'H)ones
GB8905130D0 (en) * 1989-03-07 1989-04-19 Pfizer Ltd Therapeutic agents
FR2645149A1 (da) * 1989-03-30 1990-10-05 Adir
FR2646350B1 (fr) * 1989-04-28 1991-06-28 Adir Nouveaux derives benzothiazolinoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5166353A (en) * 1989-04-28 1992-11-24 Adir Et Compagnie Benzothiazolinone compounds
KR910011852A (ko) * 1989-12-04 1991-08-07 폴 디. 매튜카이티스 신경독 장해 치료용 이미다조[1,2-a]피리디닐알킬 화합물
US5716964A (en) * 1989-12-04 1998-02-10 G.D. Searle & Co. Tetrazolyl substituted imidazo 1,2-a!pyridinylalkyl compounds for treatment of neurotoxic injury
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
HRP950330A2 (en) * 1994-07-05 1997-10-31 Ciba Geigy Ag New herbicides
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2503290C (en) 2003-03-10 2012-12-04 Altana Pharma Ag Novel process for the preparation of roflumilast
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
CA2601250C (en) 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
TW201018678A (en) 2006-01-27 2010-05-16 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
TW200813035A (en) 2006-06-19 2008-03-16 Astrazeneca Ab Novel heteroaryl substituted benzoxazoles
KR20090101469A (ko) * 2007-01-22 2009-09-28 아스트라제네카 아베 신규 헤테로아릴 치환된 이미다조〔1,2­a〕피리딘 유도체
TW200901998A (en) 2007-03-06 2009-01-16 Astrazeneca Ab Novel 2-heteroaryl substituted benzothiophenes and benzofuranes
AU2009249186B2 (en) * 2008-05-19 2014-05-22 Sunovion Pharmaceuticals Inc. Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators
AR075858A1 (es) * 2009-03-18 2011-05-04 Schering Corp Compuestos biciclicos como inhibidores de diacilglicerol aciltransferasa
US20160120863A1 (en) * 2013-05-24 2016-05-05 Iomet Pharma Ltd. Slc2a transporter inhibitors
CN107810188B (zh) * 2015-04-08 2020-09-22 拜耳作物科学股份公司 作为害虫防治剂和中间体产物的稠合双环杂环衍生物
GB201509893D0 (en) * 2015-06-08 2015-07-22 Ucb Biopharma Sprl Therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU600143A1 (ru) * 1976-12-06 1978-03-30 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвийской Сср Способ получени гетероциклических систем, содержащих бормзамещенный имидазол
JPS57102888A (en) * 1980-12-18 1982-06-26 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5782390A (en) * 1980-11-11 1982-05-22 Otsuka Pharmaceut Co Ltd Carbostyril derivative
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ZA841156B (en) 1984-09-26
ES8505963A1 (es) 1985-06-16
KR840007879A (ko) 1984-12-11
GR79810B (da) 1984-10-31
US4621084A (en) 1986-11-04
DK72784D0 (da) 1984-02-16
GB8305245D0 (en) 1983-03-30
DE3471936D1 (en) 1988-07-14
ATE34984T1 (de) 1988-06-15
AU2482284A (en) 1984-08-30
JPS59186983A (ja) 1984-10-23
NO840712L (no) 1984-08-27
FI840653A0 (fi) 1984-02-17
ES530011A0 (es) 1985-06-16
EP0120589B1 (en) 1988-06-08
JPH0557989B2 (da) 1993-08-25
FI840653A (fi) 1984-08-26
EP0120589A1 (en) 1984-10-03

Similar Documents

Publication Publication Date Title
DK72784A (da) Imidazo-heterocycliske forbindelser
NO158507C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9-halogen-7-okso-2,3-dihydro-7h-pyrido (1,2,3-de)(1,4)-benzoksazin-6-karboksylsyreforbindelser.
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
PH16815A (en) 5-(heterocyclic amino-propiionyl)-5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-ones
AU556922B2 (en) Pyridobenzodiazepinone derivatives
GB982613A (en) New aminopyrazoles and process for preparing same
DE3070227D1 (en) Benzothiazole derivatives, pharmaceutical compositions containing them and process for their preparation
IE820079L (en) Piperazinylalkylamino (or oxy) phenyl heterocycles
PT87025A (pt) Process for the preparation of imidazol derivatives and of pharmaceutical compositions containing the same
ES8407052A1 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas
DE3161553D1 (en) Thiazolo(3,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
CA2053705A1 (en) Piperazine derivatives
GR79079B (da)
JPS5283864A (en) Cephalosporin derivatives
FI921298A (fi) Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment